Back to Top
Upinitatug Biosimilar - Research Grade
$710.00 - $6,900.00
Upinitatug Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
SLC34A2ï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
O95436
Shipping Conditions
Blue ice
Background
SLC34A2 (NaPi2b) is a sodium-dependent phosphate transporter overexpressed in several epithelial tumors, drawing interest as a targeting antigen in cancer research. This product is an unconjugated, non-therapeutic analog of upinitatug, a recombinant human IgG1 antibody against SLC34A2, supplied for research use only (RUO). Manufactured to in vivo-grade, low-endotoxin specifications, it is available in scalable milligram to gram quantities for heavy-usage and high-throughput laboratories. Typical applications include antigen-binding and internalization assays, in vitro tumor-cell screening, control reagents, and preclinical models supporting targeted-therapy and ADC development workflows.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review












